Sorafenib in Treating Patients With Malignant Mesothelioma

This study is ongoing, but not recruiting participants.

Study NCT00107432 Information provided by Cancer and Leukemia Group B

First Received: April 5, 2005 Last Updated: March 22, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2014
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)

Publications:

Janne PA, Wang XF, Krug LM, et al.: Sorafenib in malignant mesothelioma (MM): a phase II trial of the Cancer and Leukemia Group B (CALGB 30307). [Abstract] J Clin Oncol 25 (Suppl 18): A-7707, 435s, 2007.